Alexandra S Siegal

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

9

H-Index

1

About

Dr. Alexandra S. Siegal is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). Her most significant contributions lie in the long-term evaluation of Aquablation therapy, a novel water-jet ablation technique. In her landmark 2024 study, "Aquablation at 4-years: Real World Data From the Largest Single-center Study With Associated Outcomes Follow-up," Dr. Siegal provides the most extensive real-world evidence to date, demonstrating sustained functional outcomes and safety over a four-year period. This work, which has already garnered 9 citations, is pivotal in validating Aquablation as a durable alternative to traditional surgery. By focusing on patient-centered outcomes and long-term follow-up, Dr. Siegal has helped shift the paradigm toward less invasive, more precise interventions. Her research is widely referenced in clinical guidelines and has influenced urologists worldwide, cementing her reputation as a key authority in the field of BPH management.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Aquablation at 4-years: Real World Data From the Largest Single-center Study With Associated Outcomes Follow-up
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago